CY1108384T1 - Διαδερμικη δοσολογια βουπρενορφινης για αναλγησια - Google Patents

Διαδερμικη δοσολογια βουπρενορφινης για αναλγησια

Info

Publication number
CY1108384T1
CY1108384T1 CY20081101079T CY081101079T CY1108384T1 CY 1108384 T1 CY1108384 T1 CY 1108384T1 CY 20081101079 T CY20081101079 T CY 20081101079T CY 081101079 T CY081101079 T CY 081101079T CY 1108384 T1 CY1108384 T1 CY 1108384T1
Authority
CY
Cyprus
Prior art keywords
dose
buprenorphine
interderative
butrenorfine
dosage
Prior art date
Application number
CY20081101079T
Other languages
Greek (el)
English (en)
Inventor
Bruce E Reidenberg
Daniel A Spyker
Original Assignee
Euro-Celtique S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Euro-Celtique S.A. filed Critical Euro-Celtique S.A.
Publication of CY1108384T1 publication Critical patent/CY1108384T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CY20081101079T 2002-12-13 2008-09-30 Διαδερμικη δοσολογια βουπρενορφινης για αναλγησια CY1108384T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US43342302P 2002-12-13 2002-12-13
EP03813444A EP1572167B1 (en) 2002-12-13 2003-12-15 Transdermal buprenorphine dosage regimen for analgesia

Publications (1)

Publication Number Publication Date
CY1108384T1 true CY1108384T1 (el) 2014-02-12

Family

ID=32595187

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20081101079T CY1108384T1 (el) 2002-12-13 2008-09-30 Διαδερμικη δοσολογια βουπρενορφινης για αναλγησια

Country Status (16)

Country Link
US (1) US7270830B2 (cg-RX-API-DMAC7.html)
EP (1) EP1572167B1 (cg-RX-API-DMAC7.html)
JP (2) JP5054893B2 (cg-RX-API-DMAC7.html)
AT (1) ATE400258T1 (cg-RX-API-DMAC7.html)
AU (2) AU2003297073A1 (cg-RX-API-DMAC7.html)
CA (1) CA2510223C (cg-RX-API-DMAC7.html)
CY (1) CY1108384T1 (cg-RX-API-DMAC7.html)
DE (1) DE60322102D1 (cg-RX-API-DMAC7.html)
DK (1) DK1572167T3 (cg-RX-API-DMAC7.html)
ES (1) ES2310262T3 (cg-RX-API-DMAC7.html)
IL (1) IL169056A (cg-RX-API-DMAC7.html)
MX (1) MXPA05006334A (cg-RX-API-DMAC7.html)
NZ (1) NZ539936A (cg-RX-API-DMAC7.html)
PT (1) PT1572167E (cg-RX-API-DMAC7.html)
SI (1) SI1572167T1 (cg-RX-API-DMAC7.html)
WO (1) WO2004054553A1 (cg-RX-API-DMAC7.html)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5968547A (en) 1997-02-24 1999-10-19 Euro-Celtique, S.A. Method of providing sustained analgesia with buprenorphine
PT2561860T (pt) * 2002-05-31 2018-05-08 Titan Pharmaceuticals Inc Dispositivo polimérico implantável para a libertação prolongada de buprenorfina
US7270830B2 (en) * 2002-12-13 2007-09-18 Purdue Pharma L.P. Transdermal buprenorphine dosage regimen for analgesia
SI1610791T1 (sl) * 2003-03-31 2011-05-31 Titan Pharmaceuticals Inc Implantibilna polimerna naprava za zadržano sproščanje dopaminskega agonista
US8790689B2 (en) * 2003-04-30 2014-07-29 Purdue Pharma L.P. Tamper resistant transdermal dosage form
BRPI0409945A (pt) * 2003-04-30 2006-04-25 Purdue Pharma Lp forma de dosagem resistente à alteração
CA2529983C (en) * 2003-07-25 2010-07-20 Euro-Celtique S.A. Preoperative treatment of post operative pain
DE602004009449T2 (de) 2003-07-25 2008-07-24 Euro-Celtique S.A. Behandlung von entzug
US20060281775A1 (en) * 2005-06-14 2006-12-14 Applied Pharmacy Services, Inc. Two-component pharmaceutical composition for the treatment of pain
US9522188B2 (en) * 2005-12-13 2016-12-20 Biodelivery Sciences International, Inc. Abuse resistant transmucosal drug delivery device
ES2577390T3 (es) 2006-07-21 2016-07-14 Biodelivery Sciences International, Inc. Dispositivos de administración transmucosa con mayor captación
DE102006054731B4 (de) * 2006-11-21 2013-02-28 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches System zur Verabreichung des Wirkstoffs Buprenorphin und Verwendung desselben in der Schmerztherapie
EP1985292A1 (en) * 2007-04-23 2008-10-29 Grünenthal GmbH Titration of tapentadol
EP2262367A4 (en) * 2008-03-08 2011-04-20 Theraquest Biosciences Inc PHARMACEUTICAL ORAL COMPOSITIONS OF BUPRENORPHINE AND METHOD FOR THEIR USE
WO2010047681A1 (en) * 2008-10-24 2010-04-29 Bridge Pharma, Inc. Treating xerophthalmia with norketotifen
WO2010059894A1 (en) * 2008-11-21 2010-05-27 Bridge Pharma, Inc. Ocular formulations of norketotifen
MX352959B (es) 2011-08-18 2017-12-15 Biodelivery Sciences Int Inc Dispositivos mucoadhesivos resistentes al abuso para el suministro de buprenorfina.
EA201491164A1 (ru) * 2011-12-12 2014-10-30 ЭлТиЭс ЛОМАНН ТЕРАПИ-ЗЮСТЕМ АГ Трансдермальная система доставки
US9901539B2 (en) 2011-12-21 2018-02-27 Biodelivery Sciences International, Inc. Transmucosal drug delivery devices for use in chronic pain relief
AU2013205080B2 (en) * 2012-12-12 2016-07-07 Lts Lohmann Therapie-Systeme Ag Transdermal Delivery System
WO2014195352A1 (en) 2013-06-04 2014-12-11 Lts Lohmann Therapie-Systeme Ag Transdermal delivery system
MX2018010367A (es) * 2016-02-29 2018-12-10 Guenenthal Gmbh Titulacion de cebranopadol.
WO2020124073A1 (en) * 2018-12-14 2020-06-18 Pear Therapeutics, Inc. A digital therapeutic component to optimize induction of buprenorphine-containing products

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA856002B (en) * 1984-08-10 1987-04-29 Du Pont Transdermal delivery of opioids
US4806341A (en) 1985-02-25 1989-02-21 Rutgers, The State University Of New Jersey Transdermal absorption dosage unit for narcotic analgesics and antagonists and process for administration
US5026556A (en) 1988-11-10 1991-06-25 Norwich Eaton Pharmaceuticals, Inc. Compositions for the transdermal delivery of pharmaceutical actives
US5240711A (en) * 1989-11-29 1993-08-31 Lts Lohmann Therapie-Systeme Gmbh & Co. Kg Transdermal therapeutic system comprising as active component buprenorphine
AU637496B2 (en) 1990-04-24 1993-05-27 Teijin Limited Plaster
US5069909A (en) 1990-06-20 1991-12-03 Cygnus Therapeutic Systems Transdermal administration of buprenorphine
US5149538A (en) * 1991-06-14 1992-09-22 Warner-Lambert Company Misuse-resistive transdermal opioid dosage form
JP2886021B2 (ja) * 1993-03-19 1999-04-26 帝三製薬株式会社 安定な貼付剤
US5613958A (en) 1993-05-12 1997-03-25 Pp Holdings Inc. Transdermal delivery systems for the modulated administration of drugs
JP2837337B2 (ja) * 1993-08-10 1998-12-16 帝三製薬株式会社 貼付剤
US5968547A (en) 1997-02-24 1999-10-19 Euro-Celtique, S.A. Method of providing sustained analgesia with buprenorphine
JP3662388B2 (ja) * 1997-05-30 2005-06-22 日東電工株式会社 経皮吸収製剤及びその製造方法
PT1485051E (pt) 2002-03-20 2008-07-09 Euro Celtique Sa Processo de administração da buprenorfina para o tratamento da depressão
US7270830B2 (en) * 2002-12-13 2007-09-18 Purdue Pharma L.P. Transdermal buprenorphine dosage regimen for analgesia
WO2004103317A2 (en) * 2003-05-15 2004-12-02 Euro-Celtique S.A. Transdermal buprenorphine dosage regimen for treatment of diarrhea
DE602004009449T2 (de) 2003-07-25 2008-07-24 Euro-Celtique S.A. Behandlung von entzug

Also Published As

Publication number Publication date
JP2006513184A (ja) 2006-04-20
PT1572167E (pt) 2008-10-03
CA2510223C (en) 2017-09-12
DK1572167T3 (da) 2008-10-13
ATE400258T1 (de) 2008-07-15
JP5054893B2 (ja) 2012-10-24
AU2010201479A1 (en) 2010-05-06
ES2310262T3 (es) 2009-01-01
SI1572167T1 (sl) 2008-12-31
US20040126416A1 (en) 2004-07-01
AU2003297073A1 (en) 2004-07-09
JP2010285457A (ja) 2010-12-24
WO2004054553A9 (en) 2005-09-15
WO2004054553A1 (en) 2004-07-01
EP1572167A1 (en) 2005-09-14
DE60322102D1 (de) 2008-08-21
EP1572167B1 (en) 2008-07-09
EP1572167A4 (en) 2007-01-10
NZ539936A (en) 2007-06-29
IL169056A (en) 2012-01-31
MXPA05006334A (es) 2005-08-26
CA2510223A1 (en) 2004-07-01
AU2010201479B2 (en) 2012-11-01
US7270830B2 (en) 2007-09-18

Similar Documents

Publication Publication Date Title
CY1108436T1 (el) Χορηγηση καψαϊκινοειδων
DK1169059T3 (da) Docetaxel i kombination med rhuMAb HER2 til behandling af cancere
ATE400258T1 (de) Transdermales buprenorphin-dosierschema zwecks schmerzstillung
TR200002786T2 (tr) Meloksikam için yeni galenik bir formülasyon.
CY1107389T1 (el) Σελεκοξιμπη σε μορφη στερεης καταστασης με ενισχυμενη βιοδιαθεσιμοτητα
CY1105501T1 (el) Συνδυασμοι φαρμακων (π.χ. chlorpromazine και pentamidine) για την αντιμετωπιση νεοπλαστικων διαταραχων
CY1115104T1 (el) Φαρμακα και μεθοδοι για την θεραπευτικη αγωγη της κεφαλαλγιας
CY1112473T1 (el) Μεθοδοι θεραπειας για καρκινους σχετιζομενους με β κυτταρα
CZ309247B6 (cs) 40-O-(2-hydroxyethyl)rapamycin pro použití jako jediná účinná látka při léčení solidního nádoru
NO20006604L (no) Fremgangsmåter og transdermale sammensetninger for lindring av smerte
CY1116215T1 (el) Θεραπεια συνδυασμου για τη θεραπευτικη αγωγη διαταραχων ανεπαρκειας πρωτεϊνης
WO2004006842A3 (en) Combinations of drugs for the treatment of neoplasms
CY1110013T1 (el) Συνδυασμοι για θεραπεια πολλαπλου μυελωματος
CY1112361T1 (el) Σκευασματα για αντικαρκινικη θεραπεια που περιεχουν εκτεϊνασκιδινη 743
UA50719C2 (uk) Проліки для терапії пухлин і запальних захворювань
CY1108401T1 (el) Παραγωγα πυρρολοϊμιδαζολης, η παρασκευη τους, φαρμακευτικες συνθεσεις που τα περιεχουν και η χρηση τους ως νοοτροπικων παραγοντων
DK0725637T3 (da) Parenteralt busulfan til behandling af malign sygdom
IS6558A (is) Blandaðar sjúkdómsmeðferðir með æðaskaðandi virkni
DE602004016376D1 (de) Kombination von et-743 mit 5-fluorouracil pro-drugs zur behandlung von krebs
BRPI0517976A (pt) métodos de tratamento
DK1750716T3 (da) Behandling af T-celle-lymfom under anvendelse af 10-propargyl-10-deazaaminopterin
NO20044498L (no) Kombinasjonsterapi for behandling av cancer
CY1113488T1 (el) Ενα φαρμακο για την δυο βαθμιδων περιεγχειρητικη θεραπεια συμπαγων ογκων δια ραδιοανοσοθεραπειας
HUP9700661A2 (hu) Alfa1-adrenoreceptor antagonisták felhasználása rák megelőzésére és kezelésére alkalmas gyógyszerkészítmények előállítására
GEP201606538B (en) Preoperative treatment of post operative pain